Annual EBITDA
-$75.64 M
-$4.46 M-6.27%
December 31, 2022
Summary
- As of February 10, 2025, BLU annual EBITDA is -$75.64 million, with the most recent change of -$4.46 million (-6.27%) on December 31, 2022.
- During the last 3 years, BLU annual EBITDA has fallen by -$49.77 million (-192.42%).
Performance
BLU EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$24.92 M
-$6.80 M-37.55%
March 31, 2023
Summary
- As of February 10, 2025, BLU quarterly EBITDA is -$24.92 million, with the most recent change of -$6.80 million (-37.55%) on March 31, 2023.
- Over the past year, BLU quarterly EBITDA has dropped by -$10.68 million (-74.97%).
Performance
BLU Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$86.31 M
-$10.68 M-14.11%
March 31, 2023
Summary
- As of February 10, 2025, BLU TTM EBITDA is -$86.31 million, with the most recent change of -$10.68 million (-14.11%) on March 31, 2023.
- Over the past year, BLU TTM EBITDA has dropped by -$16.58 million (-23.77%).
Performance
BLU TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BLU EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -6.3% | -75.0% | -23.8% |
3 y3 years | -192.4% | -147.2% | -166.7% |
5 y5 years | -5178.2% | -1647.8% | -233.7% |
BLU EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | +6.3% | at low | +75.0% | at low | +23.8% | at low |
5 y | 5-year | +192.4% | at low | +340.5% | at low | +233.7% | at low |
alltime | all time | -1905.6% | at low | -989.4% | at low | <-9999.0% | at low |
BELLUS Health EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2023 | - | -$24.92 M(+37.5%) | -$86.31 M(+14.1%) |
Dec 2022 | -$75.64 M(+6.3%) | -$18.11 M(-26.5%) | -$75.64 M(+4.4%) |
Sep 2022 | - | -$24.63 M(+32.1%) | -$72.42 M(+2.6%) |
Jun 2022 | - | -$18.65 M(+30.9%) | -$70.61 M(+1.3%) |
Mar 2022 | - | -$14.24 M(-4.4%) | -$69.74 M(-2.0%) |
Dec 2021 | -$71.17 M(+125.7%) | -$14.89 M(-34.7%) | -$71.17 M(+11.7%) |
Sep 2021 | - | -$22.83 M(+28.4%) | -$63.71 M(+36.9%) |
Jun 2021 | - | -$17.77 M(+13.4%) | -$46.55 M(+25.3%) |
Mar 2021 | - | -$15.68 M(+110.9%) | -$37.14 M(+17.8%) |
Dec 2020 | -$31.54 M(+21.9%) | -$7.43 M(+31.4%) | -$31.54 M(-7.3%) |
Sep 2020 | - | -$5.66 M(-32.4%) | -$34.03 M(-2.4%) |
Jun 2020 | - | -$8.37 M(-16.9%) | -$34.86 M(+7.7%) |
Mar 2020 | - | -$10.08 M(+1.6%) | -$32.37 M(+25.1%) |
Dec 2019 | -$25.87 M(+288.0%) | -$9.92 M(+53.0%) | -$25.87 M(+46.8%) |
Sep 2019 | - | -$6.49 M(+10.4%) | -$17.62 M(+30.6%) |
Jun 2019 | - | -$5.88 M(+64.4%) | -$13.49 M(+53.3%) |
Mar 2019 | - | -$3.58 M(+113.6%) | -$8.79 M(+32.3%) |
Dec 2018 | -$6.67 M(+365.2%) | -$1.67 M(-29.0%) | -$6.65 M(+6.4%) |
Sep 2018 | - | -$2.36 M(+98.4%) | -$6.25 M(+19.2%) |
Jun 2018 | - | -$1.19 M(-16.6%) | -$5.24 M(+38.0%) |
Mar 2018 | - | -$1.43 M(+12.0%) | -$3.80 M(+151.5%) |
Dec 2017 | -$1.43 M(-12.5%) | -$1.27 M(-5.9%) | -$1.51 M(+178.4%) |
Sep 2017 | - | -$1.35 M(-631.8%) | -$542.40 K(-255.9%) |
Jun 2017 | - | $254.50 K(-70.5%) | $347.90 K(-277.1%) |
Mar 2017 | - | $862.30 K(-382.1%) | -$196.40 K(-88.1%) |
Dec 2016 | -$1.64 M(-684.5%) | -$305.70 K(-34.0%) | -$1.65 M(+180.8%) |
Sep 2016 | - | -$463.20 K(+59.8%) | -$587.70 K(+119.7%) |
Jun 2016 | - | -$289.80 K(-51.0%) | -$267.50 K(-19.3%) |
Mar 2016 | - | -$591.70 K(-178.2%) | -$331.40 K(-230.9%) |
Dec 2015 | $280.30 K(-117.0%) | $757.00 K(-629.4%) | $253.20 K(-205.6%) |
Sep 2015 | - | -$143.00 K(-59.6%) | -$239.80 K(-67.4%) |
Jun 2015 | - | -$353.70 K(+4881.7%) | -$736.50 K(-31.6%) |
Mar 2015 | - | -$7100.00(-102.7%) | -$1.08 M(-36.1%) |
Dec 2014 | -$1.65 M(+111.6%) | $264.00 K(-141.3%) | -$1.68 M(-30.5%) |
Sep 2014 | - | -$639.70 K(-7.8%) | -$2.42 M(+217.0%) |
Jun 2014 | - | -$693.60 K(+12.7%) | -$764.20 K(-13.8%) |
Mar 2014 | - | -$615.20 K(+29.7%) | -$887.00 K(+15.3%) |
Dec 2013 | -$778.60 K(-94.0%) | -$474.20 K(-146.5%) | -$769.10 K(+104.9%) |
Sep 2013 | - | $1.02 M(-224.8%) | -$375.40 K(-76.9%) |
Jun 2013 | - | -$816.40 K(+64.2%) | -$1.63 M(-83.8%) |
Mar 2013 | - | -$497.30 K(+517.8%) | -$10.02 M(-20.9%) |
Dec 2012 | -$13.02 M(-410.8%) | -$80.50 K(-65.4%) | -$12.67 M(-37.4%) |
Sep 2012 | - | -$232.70 K(-97.5%) | -$20.24 M(+17.6%) |
Jun 2012 | - | -$9.21 M(+192.7%) | -$17.21 M(+198.7%) |
Mar 2012 | - | -$3.15 M(-58.9%) | -$5.76 M(+51.2%) |
Dec 2011 | $4.19 M | -$7.66 M(-373.3%) | -$3.81 M(+21.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2011 | - | $2.80 M(+25.0%) | -$3.14 M(-55.5%) |
Jun 2011 | - | $2.24 M(-287.6%) | -$7.06 M(-43.7%) |
Mar 2011 | - | -$1.19 M(-82.9%) | -$12.54 M(-15.2%) |
Dec 2010 | -$12.37 M(-41.8%) | -$6.99 M(+524.0%) | -$14.79 M(+43.6%) |
Sep 2010 | - | -$1.12 M(-65.4%) | -$10.30 M(-27.3%) |
Jun 2010 | - | -$3.24 M(-6.1%) | -$14.16 M(-0.4%) |
Mar 2010 | - | -$3.45 M(+38.1%) | -$14.23 M(-26.5%) |
Dec 2009 | -$21.25 M(-54.7%) | -$2.50 M(-49.9%) | -$19.37 M(-33.9%) |
Sep 2009 | - | -$4.98 M(+51.0%) | -$29.29 M(-14.3%) |
Jun 2009 | - | -$3.30 M(-61.6%) | -$34.16 M(-20.1%) |
Mar 2009 | - | -$8.59 M(-30.9%) | -$42.75 M(-9.8%) |
Dec 2008 | -$46.95 M(-30.1%) | -$12.42 M(+26.1%) | -$47.41 M(-3.0%) |
Sep 2008 | - | -$9.85 M(-17.1%) | -$48.87 M(-9.3%) |
Jun 2008 | - | -$11.89 M(-10.2%) | -$53.89 M(-10.2%) |
Mar 2008 | - | -$13.24 M(-4.6%) | -$60.03 M(-10.6%) |
Dec 2007 | -$67.16 M(+8.0%) | -$13.88 M(-6.6%) | -$67.12 M(-0.7%) |
Sep 2007 | - | -$14.87 M(-17.5%) | -$67.61 M(-2.8%) |
Jun 2007 | - | -$18.03 M(-11.3%) | -$69.57 M(+0.8%) |
Mar 2007 | - | -$20.33 M(+41.5%) | -$69.05 M(+9.2%) |
Dec 2006 | -$62.16 M(+3.5%) | -$14.37 M(-14.7%) | -$63.25 M(+2.8%) |
Sep 2006 | - | -$16.84 M(-3.8%) | -$61.51 M(+0.8%) |
Jun 2006 | - | -$17.51 M(+20.5%) | -$61.04 M(+1.6%) |
Mar 2006 | - | -$14.53 M(+15.1%) | -$60.10 M(+1.8%) |
Dec 2005 | -$60.03 M(+40.9%) | -$12.63 M(-22.9%) | -$59.02 M(-2.6%) |
Sep 2005 | - | -$16.37 M(-1.1%) | -$60.57 M(+11.3%) |
Jun 2005 | - | -$16.56 M(+23.1%) | -$54.42 M(+12.8%) |
Mar 2005 | - | -$13.45 M(-5.1%) | -$48.26 M(+14.7%) |
Dec 2004 | -$42.60 M(+271.9%) | -$14.18 M(+38.7%) | -$42.09 M(+50.8%) |
Sep 2004 | - | -$10.22 M(-1.7%) | -$27.91 M(+24.3%) |
Jun 2004 | - | -$10.40 M(+42.9%) | -$22.45 M(+21.2%) |
Mar 2004 | - | -$7.28 M(+52.8%) | -$18.52 M(-1.5%) |
Dec 2003 | -$11.46 M(-31.9%) | - | - |
Sep 2003 | - | -$4.76 M(-26.4%) | -$18.79 M(+15.0%) |
Jun 2003 | - | -$6.48 M(+79.9%) | -$16.34 M(+32.0%) |
Jun 2003 | -$16.82 M(+87.4%) | - | - |
Mar 2003 | - | -$3.60 M(-8.9%) | -$12.38 M(+3.7%) |
Dec 2002 | - | -$3.95 M(+70.8%) | -$11.94 M(+18.2%) |
Sep 2002 | - | -$2.31 M(-8.1%) | -$10.11 M(+16.4%) |
Jun 2002 | -$8.98 M(+524.0%) | -$2.52 M(-20.4%) | -$8.69 M(+102.9%) |
Mar 2002 | - | -$3.16 M(+49.7%) | -$4.28 M(+74.3%) |
Dec 2001 | - | -$2.11 M(+136.6%) | -$2.46 M(-883.0%) |
Sep 2001 | - | -$892.80 K(-147.3%) | $313.80 K(-375.3%) |
Jun 2001 | -$1.44 M(-64.8%) | $1.89 M(-241.0%) | -$114.00 K(-94.3%) |
Mar 2001 | - | -$1.34 M(-303.2%) | -$2.00 M(+202.0%) |
Dec 2000 | - | $658.30 K(-149.8%) | -$662.30 K(-49.8%) |
Sep 2000 | - | -$1.32 M | -$1.32 M |
Jun 2000 | -$4.09 M | - | - |
FAQ
- What is BELLUS Health annual EBITDA?
- What is the all time high annual EBITDA for BELLUS Health?
- What is BELLUS Health annual EBITDA year-on-year change?
- What is BELLUS Health quarterly EBITDA?
- What is the all time high quarterly EBITDA for BELLUS Health?
- What is BELLUS Health quarterly EBITDA year-on-year change?
- What is BELLUS Health TTM EBITDA?
- What is the all time high TTM EBITDA for BELLUS Health?
- What is BELLUS Health TTM EBITDA year-on-year change?
What is BELLUS Health annual EBITDA?
The current annual EBITDA of BLU is -$75.64 M
What is the all time high annual EBITDA for BELLUS Health?
BELLUS Health all-time high annual EBITDA is $4.19 M
What is BELLUS Health annual EBITDA year-on-year change?
Over the past year, BLU annual EBITDA has changed by -$4.46 M (-6.27%)
What is BELLUS Health quarterly EBITDA?
The current quarterly EBITDA of BLU is -$24.92 M
What is the all time high quarterly EBITDA for BELLUS Health?
BELLUS Health all-time high quarterly EBITDA is $2.80 M
What is BELLUS Health quarterly EBITDA year-on-year change?
Over the past year, BLU quarterly EBITDA has changed by -$10.68 M (-74.97%)
What is BELLUS Health TTM EBITDA?
The current TTM EBITDA of BLU is -$86.31 M
What is the all time high TTM EBITDA for BELLUS Health?
BELLUS Health all-time high TTM EBITDA is $347.90 K
What is BELLUS Health TTM EBITDA year-on-year change?
Over the past year, BLU TTM EBITDA has changed by -$16.58 M (-23.77%)